(Q36639112)

15 August 2017

1 reference

title

Amyloid imaging of Alzheimer's disease using Pittsburgh Compound B. (English)

1 reference

15 August 2017

0 references

0 references

Pittsburgh compound B

1 reference

Keith A Johnson

1

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Current Neurology and Neuroscience Reports

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

496-503

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-006-0052-5

15 August 2017

exact match

0 references

cites work

Neuronal structure is altered by amyloid plaques

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0052-5

In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0052-5

Neuropathology of cognitively normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0052-5

Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0052-5

X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0052-5

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0052-5

Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development

21 January 2018

1 reference

12 December 2020

Evidence for the presence of three distinct binding sites for the thioflavin T class of Alzheimer's disease PET imaging agents on beta-amyloid peptide fibrils.

1 reference

12 December 2020

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis

1 reference

12 December 2020

Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

1 reference

12 December 2020

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

1 reference

12 December 2020

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

1 reference

12 December 2020

Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.

1 reference

12 December 2020

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

12 December 2020

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

1 reference

12 December 2020

Delineation of positron emission tomography imaging agent binding sites on beta-amyloid peptide fibrils.

1 reference

12 December 2020

Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography

1 reference

12 December 2020

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

1 reference

12 December 2020

Neuropathology of Alzheimer's disease: a critical update.

1 reference

12 December 2020

Neuropathologic features of amnestic mild cognitive impairment

1 reference

12 December 2020

Novel stilbenes as probes for amyloid plaques.

1 reference

12 December 2020

Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology

1 reference

12 December 2020

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

12 December 2020

Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.

1 reference

12 December 2020

The presenilins in Alzheimer's disease--proteolysis holds the key.

1 reference

12 December 2020

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.

1 reference

12 December 2020

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain

1 reference

12 December 2020

The immune system, amyloid-beta peptide, and Alzheimer's disease

1 reference

12 December 2020

In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile

1 reference

12 December 2020

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease

1 reference

12 December 2020

The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies

1 reference

12 December 2020

Mild cognitive impairment as a diagnostic entity

1 reference

12 December 2020

Neuropathology of older persons without cognitive impairment from two community-based studies

1 reference

12 December 2020

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

12 December 2020

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

1 reference

12 December 2020

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

1 reference

12 December 2020

Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques.

1 reference

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

12 December 2020

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

1 reference

12 December 2020

A specific amyloid-beta protein assembly in the brain impairs memory

1 reference

12 December 2020

In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Alzheimer's disease. The commonest form of amyloidosis.

1 reference

12 December 2020

Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease

1 reference

12 December 2020

Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease.

1 reference

12 December 2020

IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques

1 reference

12 December 2020

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

1 reference

12 December 2020

Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

1 reference

12 December 2020

Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain.

1 reference

12 December 2020

10.1007/S11910-006-0052-5

Identifiers

DOI

1 reference

15 August 2017

1 reference